Perrigo (PRGO) Shares Outstanding (Diluted Average) (2012 - 2026)
Perrigo (PRGO) reported Shares Outstanding (Diluted Average) of $138.7 million for Q1 2026, up 0.73% year-over-year from $137.7 million in Q1 2025, and little changed quarter-over-quarter from $138.5 million in Q4 2025.
Perrigo (PRGO) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $138.7 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $138.7 million, up 0.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.7 million (up 0.73% YoY), and the FY2025 annual result was $138.5 million, up 0.8% from the prior year.
- Shares Outstanding (Diluted Average) held at $138.7 million in Q1 2026 per PRGO's latest filing, from $138.5 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $138.8 million in Q3 2025 and troughed at $134.0 million in Q2 2022.
- A 5-year average of $136.6 million and a median of $137.1 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Diluted Average) decreased 0.45% in 2022, then climbed 2.0% in 2024.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $134.5 million in 2022, then climbed by 0.59% to $135.3 million in 2023, then climbed by 1.55% to $137.4 million in 2024, then rose by 0.8% to $138.5 million in 2025, then gained by 0.14% to $138.7 million in 2026.
- Business Quant data shows PRGO's Shares Outstanding (Diluted Average) at $138.7 million in Q1 2026, $138.5 million in Q4 2025, and $138.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 138.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 138.70 Mn |
| Dec 31, 2025 | 138.50 Mn |
| Sep 27, 2025 | 138.80 Mn |
| Jun 28, 2025 | 138.20 Mn |
| Mar 29, 2025 | 137.70 Mn |
| Dec 31, 2024 | 137.40 Mn |
| Sep 28, 2024 | 137.30 Mn |
| Jun 29, 2024 | 137.10 Mn |
| Mar 30, 2024 | 137.60 Mn |
| Dec 31, 2023 | 135.30 Mn |
| Sep 30, 2023 | 136.60 Mn |
| Jul 1, 2023 | 136.60 Mn |
| Apr 1, 2023 | 134.90 Mn |
| Dec 31, 2022 | 134.50 Mn |
| Oct 1, 2022 | 134.40 Mn |
| Jul 2, 2022 | 134.30 Mn |
| Apr 2, 2022 | 134.00 Mn |
| Dec 31, 2021 | 133.60 Mn |
| Oct 2, 2021 | 133.80 Mn |
| Jul 3, 2021 | 133.40 Mn |